
America is looking to catch up to worldwide trends for sun protection.
The Food and Drug Administration announced a proposal on Dec. 11 to allow the addition of bemotrizinol to sunscreen – an ingredient that has been popular in other countries for decades.
Bemotrizinol offers more stable, longer-lasting protection against both types of UV rays that damage our skin. It has the added benefit of being gentle enough for use on young children, said the FDA announcement. And it could become available in time for next summer.
"The agency has historically moved too slowly in this area, leaving Americans with fewer options than consumers abroad. We’re continuing to modernize the regulation of sunscreen and other over-the-counter drug products,” FDA Commissioner Marty Makary said in a press statement. “Americans deserve timely access to the best safe, effective, and consumer-friendly over-the-counter products available.”
Here's what to know.
What is Bemotrizinol?
Bemotrizinol, or BEMT, is a chemical compound that absorbs both UVB and UVA rays. If those sound familiar, it's because you've probably already seen them on every bottle of sunscreen you've ever purchased. The sun emits ultraviolet (UV) radiation, the thing sunscreens are designed to protect against.
Names like UVB and UVA distinguish between the different kinds of rays that make up the radiation, according to the University of Texas MD Anderson Cancer Center. As far as our skin, the difference between the two isn't huge. Tanning and burns happen faster with UVA than UVB. And UVB can be filtered by barriers like windows and clouds.
About 95% of UV that reaches the ground is UVA, with UVB making up the additional 5%, according to the Anderson Cancer Center. Sunblock works to block both in two different ways: putting a physical barrier between your skin and the sun with minerals or by using a chemical that absorbs rays before they can reach you. BEMT is one of the latter.
Why is BEMT good for use in sunscreen?
BEMT offers a lot of what we look for in a sunscreen. It's broad-spectrum, meaning it protects against both UVA and UVB, and offers a higher Sun Protection Factor (SPF) in smaller amounts than other popular ingredients, according to Certified Laboratories and the FDA.
BEMT is more photostable than other commonly used sunscreen ingredients, meaning it breaks down in the sun more slowly. It's also oil-soluble, which makes it ideal for incorporating into creams.
It has low levels of absorption through the skin into the body and rarely causes skin irritation, which the FDA says makes it suitable for safe use in children as young as 6 months of age.
When will BEMT come to sunscreen in the US?
After its formal proposal, the FDA allows a 45-day public comment period. The agency will then issue a final order to add the ingredient if they find it to be safe.
Approvals for over-the-counter pharmaceuticals are typically faster than the one to two years it takes for a drug to be greenlit for manufacturing. The FDA told Today that it expects BEMT sunscreens to become available in summer or fall 2026.
This article originally appeared on USA TODAY: What is bemotrizinol? FDA proposes new sunscreen ingredient
latest_posts
- 1
Exploring Programming Greatness: A Survey of \Easy to use Connection points\ - 2
Top notch DSLR Cameras for Photography Devotees - 3
Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond - 4
Shipping: The Corridors of Trade and the Coming of Another Period - 5
PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
Eleven Creations And Developments That Steered History
Undeniably popular Historical centers: Where Craftsmanship and History Meet
Turning into a Sharp Financial backer: Individual budget Wins
With Obamacare premium hikes, more people opting for no coverage or cheaper plans
Wizz CEO: We’re going to invest $1 b. in Israeli market
Sean 'Diddy' Combs faces new sexual assault allegations, currently under investigation by Los Angeles Sheriff's Department
Must-Sit in front of the Programs from Europe and the US
What to know about MIT professor Nuno Loureiro and the investigation into his shooting
Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers












